Epstein–barr virus — an old dog with new tricks

New England Journal of Medicine

Volumn 332, Issue 1, 1995, Pages 55-57

  Liebowitz, David ^a  

^a UNIVERSITY OF CHICAGO MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIGEN; CD8 ANTIGEN; IMMUNOSUPPRESSIVE AGENT; VIRUS ENVELOPE PROTEIN; VIRUS NUCLEOPROTEIN;

B CELL LYMPHOMA; B LYMPHOCYTE; CHILD; CHILDHOOD CANCER; EDITORIAL; EPSTEIN BARR VIRUS; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; LEIOMYOMA; LEIOMYOSARCOMA; MUSCLE TUMOR; PRIORITY JOURNAL; T LYMPHOCYTE; VIRUS INFECTION;

ADOLESCENT; ADULT; CHILD; HERPESVIRIDAE INFECTIONS; HERPESVIRUS 4, HUMAN; HUMAN; IMMUNOCOMPROMISED HOST; LEIOMYOMA; LEIOMYOSARCOMA; MUSCLE, SMOOTH; MUSCLES; TUMOR VIRUS INFECTIONS;

EID: 0028873285     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJM199501053320112     Document Type: Editorial

References (9)

1. Liebowitz D, Kieff E. Epstein-Barr virus. In: Roizman B, Whitley RJ, Lopez C, eds. The human herpesviruses. New York: Raven Press, 1993:107-72.
2. McClain KL, Leach CT, Jenson HB, Association of Epstein-Barr virus with leiomyosarcomas in children with AIDS. N Engl J Med 1995; 332: 12-18
3. Lee ES, Locker J, Nalesnik M, The association of Epstein-Barr virus with smooth-muscle tumors occurring after organ transplantation. N Engl J Med 1995; 332: 19-25
4. Wang D, Liebowitz D, Wang F, Epstein-Barr virus latent infection membrane protein alters the human B-lymphocyte phenotype: deletion of the amino terminus abolishes activity. J Virol 1988; 62: 4173-4184
5. Wang F, Gregory C, Sample C, Epstein-Barr virus latent membrane protein (LMP1) and nuclear proteins 2 and 3C are effectors of phenotypic changes in B lymphocytes: EBNA-2 and LMP1 cooperatively induce CD23. J Virol 1990; 64: 2309-2318
6. Wang D, Liebowitz D, Kieff E An EBV membrane protein expressed in immortalized lymphocytes transforms established rodent cells. Cell 1985; 43: 831-840
7. Fahraeus R, Rymo L, Rhim JS, Klein G Morphological transformation of human keratinocytes expressing the LMP gene of Epstein-Barr virus. Nature 1990; 345: 447-449
8. Henderson S, Rowe M, Gregory C, Induction of bcl-2 expression by Epstein-Barr virus latent membrane protein 1 protects infected B cells from programmed cell death. Cell 1991; 65: 1107-1115
9. Khanna R, Burrows SR, Kurilla MG, Localization of Epstein-Barr virus cytotoxic T cell epitopes using recombinant vaccinia: implications for vaccine development. J Exp Med 1992; 176: 169-176